Jazz Pharmaceuticals Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio13.2918.6738.54
Forward P/E5.726.298.548.2310.20
P/S Ratio1.832.022.742.533.89
P/B Ratio1.822.073.251.982.51
Price/Tangible Book18.16
Price/FCF5.487.258.0710.4310.39
Price/OCF5.337.097.8910.0610.22
PEG Ratio0.370.501.140.612.62
Enterprise Value Ratios
EV/Revenue2.713.124.084.394.03
EV/EBITDA7.258.2410.1813.209.13
EV/EBIT12.8014.7317.8128.5512.44
EV/FCF8.1311.1812.0318.0710.77
Profitability & Returns
Return on Equity (ROE)0.14%0.12%-0.06%-0.09%0.07%
Return on Assets (ROA)0.05%0.05%0.05%0.03%0.08%
Return on Invested Capital (ROIC)0.11%0.10%0.10%0.07%0.18%
Return on Capital Employed (ROCE)0.08%0.08%0.09%0.04%0.13%
Leverage & Solvency Ratios
Debt/Equity1.511.551.891.560.61
Debt/EBITDA3.973.933.905.842.11
Debt/FCF4.545.434.688.222.55
Liquidity Ratios
Current Ratio4.462.242.793.234.34
Quick Ratio3.571.521.641.433.87
Efficiency Ratios
Asset Turnover0.350.340.320.330.39
Inventory Turnover0.580.430.300.371.71
Yield & Distribution Ratios
Earnings Yield0.08%0.05%-0.02%-0.04%0.03%
FCF Yield0.18%0.14%0.12%0.10%0.10%
Buyback Yield0.08%-0.15%-0.05%-0.06%0.02%